Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosa Madureira

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Breast Care (Basel, Switzerland)|September 30, 2010
Inflammatory Breast Cancer: A Case ReportZacharoula Sidiropoulou, Lurdes Ramalho, Rosa Madureira
Case Reports in Obstetrics and Gynecology|December 19, 2017
Vaginal Endosalpingiosis Case Report: A Rare Entity Presenting as Intermenstrual BleedingSara Câmara, Gustavo Mendinhos, Rosa Madureira, et al.
Translational Lung Cancer Research|April 23, 2021
Detection and quantification of <i>EGFR</i> T790M mutation in liquid biopsies by droplet digital PCRCatarina Silveira, Ana Carla Sousa, André Janeiro, et al.
American Journal of Translational Research|October 22, 2019
Loss of HER2 and disease prognosis after neoadjuvant treatment of HER2+ breast cancerFrancisco P Branco, Duarte Machado, Filipa F Silva, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Breast Care (Basel, Switzerland)|September 30, 2010
Inflammatory Breast Cancer: A Case ReportZacharoula Sidiropoulou, Lurdes Ramalho, Rosa Madureira
Case Reports in Obstetrics and Gynecology|December 19, 2017
Vaginal Endosalpingiosis Case Report: A Rare Entity Presenting as Intermenstrual BleedingSara Câmara, Gustavo Mendinhos, Rosa Madureira, et al.
Translational Lung Cancer Research|April 23, 2021
Detection and quantification of <i>EGFR</i> T790M mutation in liquid biopsies by droplet digital PCRCatarina Silveira, Ana Carla Sousa, André Janeiro, et al.
American Journal of Translational Research|October 22, 2019
Loss of HER2 and disease prognosis after neoadjuvant treatment of HER2+ breast cancerFrancisco P Branco, Duarte Machado, Filipa F Silva, et al.
Pageof 1